Analogic Corporation Announces Market Clearance Received for Multipurpose Direct Digital Radiography System
Innovative SyneRad OMNI to be Marketed by ANEXA, an Analogic Subsidiary
PEABODY, MA (November 23, 2004) – John Wood, President and CEO of Analogic Corporation (NASDAQ: ALOGE), announced today that the U.S. Food & Drug Administration (FDA) has granted 510(k) clearance for Analogic’s new multipurpose, direct Digital Radiography (DR) system. This system features the new GR17 amorphous Selenium flat-panel detector, which was developed by Analogic’s Canadian subsidiary, Anrad Corporation, and received 510(k) clearance in early November.
Designed and developed by Analogic, the new SyneRad™ OMNI DR system is being sold by ANEXA Corporation, an Analogic subsidiary, which sells digital imaging products directly to end users in select U.S. markets. John Ross, Vice President of Marketing for ANEXA, said, “We’ve designed the SyneRad OMNI to meet the clinical demands of our emergency medicine and orthopedic office customers. We’re excited to offer them a complete DR solution using groundbreaking SELENIUM2 technology. The OMNI will be formally introduced at The Radiological Society of North America (RSNA) Annual Meeting in Chicago next week.”
ANEXA’s SyneRad OMNI with SELENIUM2 detector technology provides multi-frame acquisition capability in full 17 x 17 inch fields, allowing ANEXA to provide its customers with expanded clinical utility in areas such as joint stability and motion studies.
The SyneRad OMNI, along with other ANEXA products, will be on display at RSNA 2004 in the ANEXA Booth 6549, November 28 – December 2, in Chicago, Illinois. For details on RSNA, go to http://rsna2004.rsna.org/rsna2004/V2004/index.cvn. For information on the SyneRad OMNI, or any other ANEXA product, go to www.anexanow.com.
Analogic Corporation is a leading designer and manufacturer of advanced health and security systems and subsystems sold primarily to Original Equipment Manufacturers (OEMs). The Company is recognized worldwide for advancing the state of the art in Computed Tomography (CT), Digital Radiography (DR), Ultrasound, Magnetic Resonance Imaging (MRI), Patient Monitoring, Cardiovascular Information Management, and Embedded Multiprocessing.
TERMS OF USE
© 2003 Analogic Corporation. All rights reserved